A Study of Olezarsen (Formerly Known as AKCEA-APOCIII-LRx) Administered to Patients With Familial Chylomicronemia Syndrome (FCS)
Clinical trial NCT04568434 · COMPLETED
Trial details
- NCT number
- NCT04568434
- Sponsor
- Ionis Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-18
- Primary completion
- 2023-07-14
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.